Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Finerenone”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableLooking for participantsNCT06278207
What this trial is testing

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Not applicableNot Yet RecruitingNCT07775482
What this trial is testing

Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial

Who this might be right for
Acute Kidney InjuryRenal Insufficiency,ChronicKidney Diseases
Jean-Maxime Côté 72
Not applicableNot Yet RecruitingNCT07326631
What this trial is testing

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Who this might be right for
Diabetic Kidney Disease (DKD)Heart Failure
College of Physicians and Surgeons Pakistan 120
Not applicableStudy completedNCT05640180
What this trial is testing

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Bayer 17,847
Large-scale testing (Phase 3)Looking for participantsNCT06008197
What this trial is testing

Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Who this might be right for
Heart FailureAcute Heart Failure
Colorado Prevention Center 5,200
Not applicableStudy completedNCT05703880
What this trial is testing

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 15,948
Large-scale testing (Phase 3)Looking for participantsNCT05457283
What this trial is testing

Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuriaChildren
Bayer 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07575672
What this trial is testing

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Who this might be right for
HFpEF - Heart Failure With Preserved Ejection FractionTAVI(Transcatheter Aortic Valve Implantation)Finerenone
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,832
Testing effectiveness (Phase 2)Study completedNCT01345656
What this trial is testing

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Who this might be right for
Heart Failure
Bayer 457
Post-approval studies (Phase 4)Not Yet RecruitingNCT07155694
What this trial is testing

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Washington D.C. Veterans Affairs Medical Center 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598864
What this trial is testing

"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"

Who this might be right for
Diabetic Nephropathy
Chittagong Medical College 88
Not applicableNot Yet RecruitingNCT07585526
What this trial is testing

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160
Post-approval studies (Phase 4)Enrolling By InvitationNCT07442448
What this trial is testing

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

Who this might be right for
Heart Failure and Preserved Ejection FractionHeart FailureHeart Failure and Mildly Reduced Ejection Fraction
Cathay General Hospital 40
Large-scale testing (Phase 3)Enrolling By InvitationNCT07181135
What this trial is testing

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Who this might be right for
Chronic Kidney Disease
University Medical Center Groningen 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT07523867
What this trial is testing

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Who this might be right for
Heart FailureDiabetic Kidney DiseaseHyperkalemia
Hospital de Messejana Dr. Carlos Alberto Studart Gomes 60
Testing effectiveness (Phase 2)Ended earlyNCT06818305
What this trial is testing

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Nephrectomy+1 more
Jinling Hospital, China 10
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Not applicableStudy completedNCT04477707
What this trial is testing

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

Who this might be right for
Diabetic Retinopathy
Bayer 206
Testing effectiveness (Phase 2)Study completedNCT06835322
What this trial is testing

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Who this might be right for
Glomerulonephritis
Alexandria University 100
Not applicableLooking for participantsNCT07056595
What this trial is testing

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Who this might be right for
IgA Nephropathy (IgAN)
Botkin Hospital 30
Next Page